TG Therapeutics, INC.
SEC CIK 1001316 · TGTXD · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Charney Laurence N | Director | filed 2012 - 2026 |
| Echelard Yann | Director | filed 2012 - 2026 |
| Hoberman Kenneth | Director | filed 2014 - 2026 |
| Hume Daniel | Director | filed 2015 - 2026 |
| Lonial Sagar | Director | filed 2020 - 2026 |
| Weiss Michael S | Director · See Remarks | filed 2012 - 2026 |
| Kennedy William James | Director | filed 2012 - 2020 |
| Schoenebaum Mark | Director | filed 2012 - 2018 |
| Herskowitz Neil | Director | filed 2006 - 2014 |
| Morville Malcolm | Director | filed 2010 - 2010 |
| Shimko David | Director | filed 2010 - 2010 |
| Weiser Michael | Director | filed 2006 - 2010 |
| Mcinerney Timothy | Director | filed 2006 - 2010 |
| Steinhart Richard I | Director | filed 2007 - 2010 |
| Hoenlein Malcolm | Director | filed 2007 - 2010 |
| Abel Douglas | Director · President and CEO | filed 2006 - 2010 |
| Gimbert Joan Pons | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Power Sean A | Chief Financial Officer | filed 2012 - 2026 |
| Mcguinness Michael | Chief Financial Officer | filed 2006 - 2010 |
| Harris Alan G | Chief Medical Officer | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.